NLS Pharmaceutics (NLSPW) Competitors $0.0035 0.00 (-14.63%) As of 05/1/2025 11:35 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock NLSPW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUWShould you be buying NLS Pharmaceutics stock or one of its competitors? The main competitors of NLS Pharmaceutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. NLS Pharmaceutics vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity 180 Life Sciences (NASDAQ:ATNFW) and NLS Pharmaceutics (NASDAQ:NLSPW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings, community ranking and dividends. Is ATNFW or NLSPW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A NLS Pharmaceutics N/A N/A N/A Does the media refer more to ATNFW or NLSPW? In the previous week, 180 Life Sciences had 1 more articles in the media than NLS Pharmaceutics. MarketBeat recorded 2 mentions for 180 Life Sciences and 1 mentions for NLS Pharmaceutics. NLS Pharmaceutics' average media sentiment score of 1.87 beat 180 Life Sciences' score of 1.24 indicating that NLS Pharmaceutics is being referred to more favorably in the news media. Company Overall Sentiment 180 Life Sciences Positive NLS Pharmaceutics Very Positive Does the MarketBeat Community prefer ATNFW or NLSPW? 180 Life Sciences and NLS Pharmaceutics both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/ANLS PharmaceuticsN/AN/A Which has preferable valuation and earnings, ATNFW or NLSPW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ANLS PharmaceuticsN/AN/AN/AN/AN/A Summary180 Life Sciences and NLS Pharmaceutics tied by winning 1 of the 2 factors compared between the two stocks. Get NLS Pharmaceutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NLSPW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NLSPW vs. The Competition Export to ExcelMetricNLS PharmaceuticsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$125.17M$5.54B$7.93BDividend YieldN/A3.69%5.09%4.23%P/E RatioN/A3.2522.6018.55Price / SalesN/A4,312.34400.01103.29Price / CashN/A13.0238.1834.62Price / BookN/A34.316.774.25Net IncomeN/A-$90.45M$3.22B$248.18M7 Day PerformanceN/A1.56%1.10%0.91%1 Month PerformanceN/A4.77%2.48%2.58%1 Year PerformanceN/A96.14%15.71%4.02% NLS Pharmaceutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NLSPWNLS PharmaceuticsN/A$0.00-14.6%N/A-91.0%$0.00N/A0.006Positive NewsGap DownATNFW180 Life SciencesN/A$0.01-2.5%N/A-22.1%$0.00N/A0.007Gap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.02+22.1%N/AN/A$0.00N/A0.002Gap DownAIMDWAinosN/A$0.09+9.6%N/AN/A$0.00$20,729.000.0040Gap DownALVOWAlvotechN/A$1.11-14.6%N/A-53.7%$0.00$489.68M0.004Short Interest ↑News CoverageNegative NewsGap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03flatN/A-78.3%$0.00N/A0.0015BFRIWBiofronteraN/A$0.05-29.5%N/AN/A$0.00$37.32M0.0070Positive NewsBTMDWbioteN/A$0.01-2.3%N/A-89.9%$0.00$197.19M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.13+43.5%N/A-87.0%$0.00N/A0.008Gap UpHigh Trading VolumeCELUWCelularityN/A$0.04+9.4%N/A+3.3%$0.00$48.20M0.00220Positive News Related Companies and Tools Related Companies 180 Life Sciences Alternatives 4D pharma Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Biofrontera Alternatives biote Alternatives BriaCell Therapeutics Alternatives Celularity Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NLSPW) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NLS Pharmaceutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share NLS Pharmaceutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NLSPW Stock Free NLSPW Stock Alerts